Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662579-23-000062
Filing Date
2023-06-16
Accepted
2023-06-16 16:25:55
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686947141.html 4  
1 FORM 4 wk-form4_1686947141.xml 4 3944
  Complete submission text file 0001662579-23-000062.txt   5357
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address
Anderson Kenneth Carl (Reporting) CIK: 0001824862 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 231021543